Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 28.23% to -9 cents per share on November 05

Q3'26

Est.

$-0.09

Q1'26

Missed

by $0.07

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.10

The last earnings report on May 14 showed earnings per share of -12 cents, missing the estimate of -5 cents. With 3.58M shares outstanding, the current market capitalization sits at 293.73M.

View a ticker or compare two or three

IVVD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days